The objective of the present study was to examine the effects of the antiprogesterone RU486 on the expression levels of multiple gap junction (GI) gene products and, in detail, on a, (connexin43 [Cx43]), in various regions of the rat implantation chamber during experimentally induced preterm labor at mid/ late stages of gestation. Vaginal bleeding, but not expulsion of concepti, was observed in a majority of animals 24 h after a single injection of RU486 at Day 15 of gestation, and it persisted until animals were killed 48 h later. The bleeding was completely suppressed by R 5020, a synthetic progesterone with a high affinity for the progesterone receptor (PR). Various components of the implantation chamber (uterus, mesometrial stroma, placenta) and ovaries were isolated 24 and 48 h postinjection and analyzed for a, (Cx43), 13 (Cx32), and 132 (Cx26) connexin expression by immunohistochemistry and by Northern blots (a, only). a, Connexin was present at high levels in the myometrium following the inhibition of progesterone action by RU486; accordingly, this effect was completely suppressed by R 5020. The blocking of the PR also had a dramatic effect on expression levels, size, and distribution of junctional plaques composed of , and 132 connexins in polarized luminal and glandular epithelium. The average size of junctional plaques was significantly reduced in the luminal epithelium after RU486 administration. This effect was inhibited in the presence of R 5020. At the RNA level, the a, transcript was markedly elevated in the uterus and in the ovaries 24 and 48 h after administration of RU486. An elevation was also observed in the mesometrial stroma, while no increase was detected in the placenta. The RU486-induced a, mRNA steady-state levels in various tissues were completely suppressed by R 5020. These results demonstrate the modulation of multiple connexins in various cell types of the implantation chamber upon blocking of PR action. The expression profile of the myometrial and epithelial GJs was similar to that previously observed in the estrogen-treated rat uterus.
INTRODUCTION
Gap junctions (GJs) are dynamic intercellular contacts composed of aggregates of cell-to-cell communication channels. These channels are formed by oligomerization of structural proteins, called connexins (Cx) , that belong to a multigene family [1, 2] . Although GJ channels appear to be instrumental in controlling proliferation, differentiation, and the homeostasis of multiple cell populations within an organ, the evidence supporting their physiological role is mainly circumstantial. In spite of significant progress that has been made in characterizing the structural diversity of the connexin multigene family and its utilization in several systems in vivo, the functional significance of GJ channels and their biological role(s) in reproduction remain poorly understood [3] .
Recent reports on utilization and modulation of multiple GJ gene products by various components of the implantation chamber [4, 5] suggest that the expression of different connexins is under the control of the ovarian steroid hormones-estrogen (E 2 ) and progesterone (P). The subtle interplay of maternal E 2 and P, together with their corresponding receptors (E 2 R and PR), in controlling the process of implantation and parturition is well documented [6, 7] . A change in the maternal E 2 :P ratio also correlates well with the expression and modulation of several GJ gene products. A high E2:P ratio (E 2 dominance) leads to formation of al (Cx43) GJs in the myometrium of pregnant rats prior to delivery and in that of immature rats after treatment with E 2 [8] [9] [10] [11] [12] [13] . Interestingly, while a high P:E 2 ratio (P dominance) had a suppressive effect on E 2 -induced al GJs in the myometrium, a synergistic effect was observed for the increased expression of i (Cx32) and 2 (Cx26) connexins in the uterine luminal epithelium of rats treated with E 2 +P [13] . The importance of P in the mechanism of labor and delivery has been substantiated by studies using the antiprogesterone RU486, a potent antagonist for the PR [14, 15] . The formation of GJs has been reported in the myometrium of RU486-treated rats during early (Day 7) and late (Day 16) stages of pregnancy [10, 16] . In both studies, GJ formation was associated with uterine contractions and termination of pregnancy.
In the present study, we used the pregnant rat as a model to investigate the effects of blocking P action on the expression of three different GJ gene products (atl, 1,, and 12) in experimentally induced preterm labor. A cell typeand steroid hormone-specific modulation for different connexins has been observed in various components of the implantation chamber at both the antigen and transcript level after a single injection of the antiprogesterone RU486 (10 mg/kg) at Day 15 of gestation. The modulation of all three connexins resembled that previously described in the E 2 -dominated rat uterus. The present findings, together with those for the E 2 -and P-treated rat uterus [8, 12, 13, 16] , provide further evidence for steroid hormone-regulated GJ gene expression in the female reproductive tract.
MATERIALS AND METHODS

Treatment of Pregnant Animals with Steroid Hormones and Tissue Collection
All experiments were approved by the Institutional Animal Care Committee and conducted in accordance with Institutional regulations. Timed-pregnant Wistar rats (220-250 g BW), with a gestational period of 22 days, were purchased from Simonsen (Gilroy, CA). The pregnant rats (Day 0 was defined as the day a vaginal plug was present) were housed individually on a 12L: 12D cycle and provided with a Purina diet (Ralston-Purina, St. Louis, MO) and water ad libitum. The animals were divided into three groups (10 animals per group) and treated with steroid hormones as described previously [17] . The antiprogesterone RU486 was obtained from the manufacturer, Roussel-Uclaf (Romainville, France), as a micronized powder. The synthetic progesterone R 5020 was purchased from Du Pont (Wilmington, DE). Steroid hormones were dissolved in a small volume of ethanol (1/10 of the final volume), then adjusted to the final concentration with sesame oil, and heated for 15 min at 60 0 C to evaporate the ethanol. Animals were injected s.c. on the morning of Day 15 of gestation. Group 1 (controls) received the vehicle only. Group 2 received a single injection of RU486 at a concentration of 10 mg/ml, corresponding to a contragestive dose of 10 mg/kg BW. Group 3 received a single dose of RU486 (as in group 2) and R 5020, which was administered in 0.2-ml volume at a dosage of 5 mg/animal every 12 h until the time the animal was killed. These doses were chosen to correlate with a previous investigation on the effect of RU486 on the formation of GJs during preterm labor in the rat myometrium [17] . Five animals of each group were killed on the morning of Day 16 and the other five the following morning (24 h or 48 h after the first injection, respectively) by decapitation following a mild anesthesia with CO 2 . Implantation chambers (see Fig. 1 ) with intact concepti were isolated as described previously [5] , embedded in O.C.T compound (Tissue-tek; Miles Lab., Inc., Naperville, IL), and subjected to immunohistochemical analysis. For Northern blot analysis, uteri were cut at the edge of the placental attachment site and separated from the placenta and fetuses. The mesometrial stroma, a transitory tissue of the pregnant uterus also known as the "metrial gland," was removed and frozen in liquid nitrogen. In addition to uteroplacental components of the implantation chamber, ovaries were also isolated and subjected to RNA analysis.
Immunohistochemistry
Indirect immunohistochemistry was performed on cryostat sections (-5 jim in thickness) of fresh-frozen, O.C.T.-embedded implantation chambers with use of affinity-purified monoclonal (mAb) and polyclonal (pAb) antibodies raised against aotS, 1S, and 3 2 J connexin peptides [4, 13] .
The aotS peptide (NH 2 -RASSRPRPDDLE) extends from residues 370 to 381 and corresponds to the carboxy terminus of the otl GJ protein. The 3IS peptide (NH 2 -ILRRSPGTGAGLAEKSDR) extends from residues 262 to 280 and corresponds to the carboxy terminus of the 31 GJ protein. The [3 2 J peptide (NH 2 -KNEFKDIEEIKTQK) extends from residues 112 to 125 and corresponds to the cytoplasmic loop of the 32 connexin. The specificities of antibodies were confirmed in control experiments by incubation of the sections with preimmune rabbit IgG (5-10 jig/ml incubation volume) or by antibody binding competition experiments in which the corresponding peptides (10 ig/ml) were added to the incubation solution. Double immunolabeling experiments for localization of 31 and 32 connexins were also performed by using a combination of rabbit polyclonal and mouse monoclonal primary antibodies. Accordingly, 1IS mAb was coincubated with 3 2 J pAb, or I3S pAb was used in combination with 2 J mAb. The sections were blocked in PBS (10 mM sodium phosphate, 0.9% sodium chloride, pH 7.4) containing 3% BSA and 3% normal goat serum (blocking solution) for 1 h at room temperature, washed in PBS, and incubated with primary antibodies at room temperature for 1 h. After being washed with PBS, the slides were incubated with goat anti-rabbit (GAR) and/or goat anti-mouse (GAM) secondary antibodies (Southern Biotech. Assoc. Inc., Birmingham, AL) conjugated to fluorescein or rhodamine isothiocyanate for I h at room temperature. Both the primary and secondary antibodies were diluted 1:100 with blocking solution. The slides were washed in PBS, air dried, mounted in an antifade medium (Slowfade; Molecular Probes, Inc., Eugene, OR), and examined using a Zeiss Axiophot microscope equipped with epifluorescence (Carl Zeiss, Oberkochen, Germany).
Laser Scanning Confocal Microscopy and Image Analysis
For quantitative evaluation of GJs, immunolabeled sections were examined by a laser scanning confocal microscope (Bio-Rad MRC 600; Hercules, CA) equipped with an argon/krypton mixed gas laser. The localization of alS mouse mAb or rabbit pAb to myometrial GJs was visualized with GAM or GAR antibodies, conjugated to fluorescein. The localization of mouse mAb and rabbit pAb to epithelial GJs was visualized with GAM or GAR antibodies, conjugated to fluorescein or rhodamine, respectively. The co-localization of 13 and 32 connexins to the same junctional plaque in the luminal epithelium was demonstrated by superimposition of the recorded images of separate fluorescein ( = 488 nm; blue excitation line) and rhodamine ( 2 = 568 nm; yellow excitation line) channels. For data collection, the gain and black levels were set to ensure that the analyzed images reflected the full range of gray-level values from black (0 pixel intensity) to maximal white (255 pixel intensity). Section planes were collected in 200-nm steps in the z-axis using Kalman averaging and a zoom setting of 1 or more. In some instances, z-axis projections were reconstructed to illustrate the immunostaining at intercellular contacts of luminal epithelium. A single optical plane was then selected from simultaneous projections of the rhodamine and fluorescein channels, which were subsequently merged. To reduce the variability and inconsistency of the background staining between different sections and different animals, only well-contrasted GJs were used for analysis. Accordingly, the junctional surface area was determined by recording the images with pixel intensities in the range of 126-255. Myometrial and epithelial GJs were analyzed in five randomly selected areas in the antimesometrial region of each uterus of all five rats within each group. Morphometric analysis was carried out using Image-Pro Plus software, version 1.1 (Media Cybernetics, Silver Spring, MD). Myometrial GJs were analyzed quantitatively in the longitudinal smooth muscle by counting the number (frequency) and measuring the surface area of individually stained GJs in an area corresponding to 1000 jm 2 of smooth muscle. For quantitative analysis of GJs in the luminal epithelium, the area of interest was first defined by outlining the displayed epithelium with a mouse-driven pointer. Typically, GJs were analyzed in an area of interest that corresponded to 1000-3000 jim 2 of the luminal epithelium. The surface area of each GJ was computed in pixels and then converted to jim 2 . Data were analyzed statistically to assess for significant differences of defined GJ parameters between different treatment groups.
Extraction of Nucleic Acids, Normalization of Poly(A)+ RNA, and Northern Blot Analysis
Extraction of RNA and Northern blot analysis were performed on tissues that had been divided into two parts. In experiment 1, one half of the material corresponding to five animals within each group was pooled and used for isolation of RNA. The results of this experiment were used to FIG. 1. The rat implantation chamber illustrating the structural components that were examined for the expression of multiple GJ gene products by immunohistochemistry and Northern blots. A) The implantation chamber consists of the conceptus (fetus, extraembryonic membranes, and fetal part of the placenta) and the uterus. The chamber was fresh-frozen in O.C.T. compound and analyzed immunohistochemically with peptide antibodies specific for ox (Cx43), I3 (Cx32), and 132 (Cx26) connexins. The dashed line indicates the plane of the sections. B) The implantation chamber after lateral cut of the uterus. The uterus, consisting of the myometrium, endometrial stroma, and epithelium, was separated from the mesometrial stroma by cutting along the placental attachment site (dashed line). Uterus, mesometrial stroma, placenta, and ovaries (not shown) were isolated from individual rats and used for RNA extraction and transcript analysis. In addition, RNA was extracted from the same components that were pooled within each group. Scale bar, 10 mm (shown in 1 mm increments).
demonstrate the differences in steady-state mRNA levels between different groups. In experiment 2, the other half of the material was isolated separately from each rat. This experiment was performed to assess for the variability between individual animals within each group. Liquid nitrogen frozen samples were pulverized under N 2 atmosphere; homogenized in buffer containing 4 M guanidine isothiocyanate, 25 mM sodium citrate, 100 mM -mercaptoethanol, and 0.5% sarkosyl (pH 7.0); and sedimented through a CsCl cushion by ultracentrifugation [18] . Total RNA was quantified by absorbance at 260 nm and normalized for equal amounts of poly(A) + RNA by dot blot and hybridization with [ 3 2 -P]-end-labeled oligo(dT) [19] . Samples of RNA that contained equivalent amounts of poly(A) + RNA within the same organ for different treatment groups were used for Northern blot analysis. The normalized aliquots of total RNA were separated by electrophoresis on 1% agarose/0.6 M formaldehyde gels, stained with ethidium bromide, and transferred to nylon membranes (MSI, Westboro, MA) by overnight capillary blotting. After baking for 2 h at 80°C, the membranes were prehybridized for 1 h at 37°C in hybridization buffer (50% formamide, 5-strength SSPE [single-strength SSPE = 150 mM NaCl, 10 mM NaH 2 PO 4 , 1 mM Na/EDTA], 5-strength Denhardt's [single-strength Denhardt's = 0.02% polyvinylpyrrolidone, 0.02% BSA, 0.02% ficoll 400]) and 100 pxg/ml tRNA and hybridized overnight at 50C with a cDNA probe specific for otI connexin [4] . As an internal standard, the blots were rehybridized with a cDNA clone coding for human j3-actin [20] . Complementary DNA probes were prepared by isolation of the excised fragments and random primer labeling using a multiprime DNA labeling kit (Amersham, Arlington Heights, IL). Each probe was labeled to a specific activity of approximately 1 109 cpm/lig DNA. Membranes were washed in double-strength SSC (single-strength SSC = 150 mM NaC1, 15 mM sodium citrate, pH 7.0) at room temperature two times, 30 min each, and then washed in 0.5-strength SSC at 65C. Blots were processed by autoradiography at -70C using Kodak XAR-5 film (Eastman Kodak, Rochester, NY) with an intensifying screen at variable time intervals to determine the linearity in x-ray response. Resulting blots were analyzed with an LKB laser scanner densitometer (UltroScan IL, Bromma, Sweden) to calculate the relative abundance of steady-state mRNA levels. The mRNA content for a given tissue was then expressed as arbitrary units; to calculate these, the transcript level of the corresponding control group was set equal to 1.0. The abundance of each of the other transcripts was then expressed as a fold change from that value. Data from densitometric estimations were subjected to statistical analysis to assess for significant differences between various treatment groups.
Statistical Analysis
Statistical analysis was performed with use of PC-SAS (Statistical Analysis Systems) software [21] . All data were expressed as sample mean + SD and were initially examined by one-way ANOVA. Significant differences between means of different groups were analyzed by Student's ttest. Differences were considered significant if p < 0.05.
RESULTS
Effects of the Antiprogesterone RU486 on the Implantation Chamber at Late Stages of Gestation: Gross Anatomical Changes
The administration of RU486 to Day 15 pregnant rats at a contragestive dose of 10 mg/kg was marked by vaginal bleeding in 3 of 10 rats 12 h after injection. In the morning of Day 16 (24 h postinjection), the number of animals with bleeding increased to 7. Bleeding was observed in all ani- mals at 48 h after administration of a single injection of the antiprogesterone RU486. Fetuses, however, were not expelled at any point in this study. Bleeding did not occur in the controls or in animals treated with RU486+R 5020. Figure 1 illustrates the gross anatomical components of the rat implantation chamber during a late stage of pregnancy. Histological correlates of the chamber, emphasizing the structural relationship between the developing conceptus and the uterus, have been described previously [5] . Striking differences were noted when the implantation chambers of the control or RU486+R 5020 groups were compared with those of the RU486 group upon isolation of the tissue at both 24 and 48 h. The implantation chambers of the control and RU486+R 5020-treated animals contained large and well-vascularized placenta with a firm attachment to the mesometrial stroma. The uterine wall, which encompassed the entire chamber, was soft. In contrast, in the animals treated with RU486, several tissues of the implantation chamber were smaller in size than those of the control and RU486+R 5020 groups. The size reduction was due primarily to a smaller placenta and mesometrial stroma and a decreased fetal size. The placenta was less vascularized as indicated by the pale appearance of the tissue. The attachment of the placenta to the mesometrial stroma was less tenacious, since the placenta was easily removed from the uterus. The mesometrial stroma (metrial gland) was smaller than that of the control group, and the uterine wall was rigid.
Effects of the Antiprogesterone RU486 on Multiple GJ Gene Products in Different Components of the Implantation Chamber
GJ gene products were examined immunohistochemically in tissue sections of all five animals within a group. Differences in staining properties for the three connexins were not observed between animals of the same group. Thus, the images illustrating junctional staining in specific tissues are representative for all five rats of the same group. In addition to qualitative analysis by conventional epifluorescence microscopy, myometrial and epithelial GJs were also examined by laser scanning confocal microscopy in the antimesometrial region of the uterus. The recorded images were subsequently used for quantitative analysis in which the frequency and the surface area of individual GJs were measured. The results of the quantitative and statistical analyses are summarized in Table 1 . The expression and distribution of a, connexin in the myometrial and endometrial components of the Day 16 uterus are illustrated in Figure 2 . Conventional epifluorescence microscopy did not detect al antigen in either layer of the myometrial smooth muscle (Fig. 2A) or in the subepithelial region of the endometrial stroma in the uteri of control group animals (Fig. 2D) . Within the myometrium, the staining of al antigen was mainly confined to the fibroblasts of the connective tissue matrix. The small size of individual GJs (0.12 + 0.10 pum 2 ) and low frequency of junctional staining (3.5 + 0.4 GJs per 1000 lum 2 tissue) were also reflected in the overall junctional surface area, which amounted to 0.43 0.08 [xm 2 /1000 Vim 2 longitudinal smooth muscle. In contrast, a high level of at connexin was detected in the myometrium of animals treated with RU486. In both circular and longitudinal smooth muscle layers (Fig. 2B) , as well as in the stromal compartment proximal to the basement membrane (Fig. 2E) , al was abundant. The average area of junctional staining, as well as the frequency and the total surface area of myometrial GJs, was significantly (p < 0.01) increased in RU486-treated rats as compared to the control. The average surface area of individual plaques increased 2-fold (0.22 + 0.13 jim 2 ) and the frequency increased 9-fold (31.2 _ 5.9), resulting in a 14-fold increase (6.10 + 1.20 pim 2 ) of the total junctional surface area in the longitudinal smooth muscle. Co-administration of R 5020 with RU486 completely inhibited the expression of al connexin in the longitudinal (outer) layer of the myometrium, while the abundance was dramatically decreased in the circular (inner) layer of the myometrium (Fig. 2C) . In the endometrial stroma proximal to the luminal epithelium, al antigen was also not observed (Fig. 2F) . Accordingly, the expression profile of a, connexin in the RU486+R 5020-treated group resembled more closely that of the control group than that of the RU486-treated group. There were no statistically significant differences when the sample means for all junctional parameters of the control and RU486+R 5020 groups were compared. Absence of detectable a, antigen in the myometrium and in the subepithelial region of the endometrial stroma (es) of the control group. B, E) High level of a, antigen in the circular (me) and longitudinal (ml) smooth muscle layer of the myometrium 24 h after RU486 administration. Note the accumulation of a, staining in the subepithelial region of the endometrial stroma (arrows in B). C, F) Co-administration of the progesterone agonist R 5020 completely inhibited RU486-induced a, expression in the myometrium and in the endometrial stroma proximal to the basement membrane. Immunohistochemically, the expression pattern of animals treated with RU486+R 5020 resembled that of the control group. Results of the quantitative and statistical analysis of myometrial GJs are summarized in Table 1 . Scale bar for A-C, 50 Im; for D-F, 25 ,Im.
As seen in Figure 3 , al antigen was also present at relatively high levels in the mesometrial stroma (metrial gland) and in the decidua basalis of the placenta of controls. The distribution of al GJs in the mesometrial stroma resembled a gradient with a varying abundance relative to the distance from the vascularized region (Fig. 3, A and B) . In addition to an abundant expression in the decidua basalis (Fig. 3, C and D) , l antigen was also detected in the adjacent layer of the placenta between trophoblast giant cells. RU486 treatment had no noticeable effect on the expression level of ai connexin in the mesometrial stroma or in the placenta. Its abundance and distribution were similar in appearance to what is seen in Figure 3 , B and D (data not shown).
In contrast to uol, the expression and distribution of 3 connexins were confined to the epithelial tissues within the uterus; 31 and [32 antigens were not observed in the myometrium. The expression and distribution of 3 connexins in the luminal epithelium of the antimesometrial portion of the Day 16 pregnant uterus are illustrated in Figure 4 . The results of the quantitative and statistical analysis are summarized in Table 1 . Regions with extensive staining of 31 and [32 antigens were found primarily at the subapical-lateral cell borders of the epithelium in the controls (Fig. 4,  A and D . Upon administration of RU486, morphological changes were observed in epithelial cells lining the uterine lumen. These cells were elongated as compared to the controls, and the morphological alterations were associated with dramatic changes in the size, distribution, and abundance of epithelial GJs. The staining indicated the presence of small GJs that were mainly localized at the basolateral cell borders (Fig. 4, B and E) . The basolateral localization was particularly noticeable for 32 connexin, with the antigen being present in the vicinity of the basement membrane (Fig. 4E) . The average surface area FIG. 3 . Representative illustration of a, GJ antigen in the mesometrial stroma and placenta of Day 16 pregnant uterus. A, B) a, Antigen was expressed at high levels in the mesometrial stroma (ms) and in the maternal portion of the placenta (decidua basalis; db) in animals of the control group. Note the gradient of a, antigen abundance relative to the distance from the vascularized region (bv = blood vessel). C, D) In addition to a high abundance in the decidua basalis (db), a, antigen was present also between the trophoblast giant cells (gc). These cells formed the interface between the maternal and fetal portions of the placenta. Differences in a, expression were not observed in either the mesometrial stroma or the placenta after administration of RU486, with or without R 5020. Scale bar, 50 Im.
of GJ plaques containing PI and 2 connexins was significantly reduced (p < 0.01) as compared to the control group, amounting to 0.8 0. Consequently, the dramatic reduction of the PI junctional area, which amounted to 17 5.7 pim 2 per 1000 pam 2 tissue, was attributable to a decrease in the junctional frequency combined with a reduced area of individual junctions. Though the junctional area containing 32 connexin was also significantly reduced (p < 0.05) in RU486-dominated epithelium (128 + 15 pm 2 per 1000 pxm 2 tissue), this reduction was due exclusively to a decrease in individual plaque sizes of 32 GJs. In contrast to PI, the frequency of immunostained 32 GJs was significantly increased (p < 0.01) as compared with that of the control epithelium. Taken together, these results demonstrate a differential effect of the antiprogesterone RU486 on the molecular composition and abundance of epithelial GJ plaques composed of 3 i and 132 connexins. This effect, however, was completely suppressed by the synthetic progesterone R 5020. The luminal epithelium of the group treated with RU486+R 5020 resembled that of the control group, morphologically and immunohistochemically. The cells were shorter in length, and they contained extensive areas of 31 and 32 junctional staining with subapical-lateral localizations (Fig. 4, C and F) . Quantitative and statistical analysis revealed no significant differences between the RU486+R 5020 group and the control group (Table 1) .
To demonstrate the co-localization of 3 I and 132 connexins within the same GJ plaque of the luminal epithelium, uterine sections of the control and RU486+R 5020 group were also double immunolabeled using rabbit polyclonal and mouse monoclonal connexin antibodies. The labeling properties of both antibodies were examined by laser scanning confocal microscopy. The co-localization of 1 (green) and 132 (red) antigens within the same GJ plaque (yellow) is illustrated in Figure 5 . In addition to large yellow-stained areas with an average size of approximately 15 ILm 2 , smaller regions of green or red fluorescence were also observed. This staining indicates the presence of smaller GJs, formed predominantly of 1 (green) or 32 (red) connexins. The localization of immunostained areas to intercellular contacts of epithelial cells suggests plasma membrane-associated 3 and 32 connexins (Fig. 5D) . Intracellular staining, indicative of cytoplasmic GJs, was not observed in the material examined.
As compared to the luminal epithelium, the cells of the glandular epithelium exhibited a different expression profile for 3 and 132 connexins (Fig. 6) . The most striking difference was the absence of both antigens during P-dominated mid/late stages of gestation (Fig. 6, A and D) . Similar to what was observed in luminal epithelium, and 32 con- Fig. 5) . B, E) Co-expression of P, and 32 connexins in basolateral regions of the luminal epithelium after administration of RU486. There is a significantly reduced level of p, expression (B) as compared to that for the control group. In addition, GJs containing 32 connexin (E) were increased in number but reduced in size when compared to those of the other two groups. C, F) Co-expression of P, and 32 connexins in the luminal epithelium of animals treated with RU486+R 5020. Immunohistochemically, the expression pattern and the junctional surface areas resembled those of the control group. The results of the quantitative and statistical analysis of epithelial GJs are summarized in Table 1 . Scale bar, 25 Cim.
nexins were also differentially expressed in the glandular epithelium after administration of the antiprogesterone RU486. While 3I antigen was not detected (Fig. 6B) , [32 antigen was observed in the epithelium of many, but not all, uterine glands of a single uterus (Fig. 6E) . Analogous to findings for the control group, both connexins were absent in the glandular epithelium of the group treated with RU486+R 5020 (Fig. 6, C and F) . In addition to the epithelial expression of 32 connexin in the uterus, 2 antigen was also detected at high levels in the decidua basalis and in chorionic villi of the placenta (data not shown). In these tissues, no differences were observed in 2 expression levels between various treatment groups. In summary, the utilization of uterine GJs following the blocking of P action by RU486 was similar to that previously reported for the E 2 -dominated rat uterus [13] .
Effects of the Antiprogesterone RU486 on Steady-State Levels of a, GJ mRNA in Various Tissues
The components of the implantation chamber used for RNA extraction are presented in Figure 1 . These components were isolated from all rats used in the present study. Subsequently, RNA was extracted either from individual components of each rat or from material pooled from all five rats in each group. The results of the Northern blot analysis are summarized in Figure 7 . The analysis of combined material was carried out to compare for differences between treatment groups (Fig. 7A) . In addition, analysis of individual rats was also performed to monitor for transcript variability within each group (Fig. 7B) . A single injection of the antiprogesterone RU486 resulted in a significant increase (p < 0.01) of the a 1 mRNA (3.3 kb) steady-state level in the uterus. Its abundance increased 15-fold above the control value 24 h after treatment and remained constant at 48 h. The steady-state levels of [-actin mRNA (2.0 kb) were not affected by RU486. The RU486-induced elevation of al mRNA was completely suppressed by the P analog R 5020. Rehybridization of uterine samples with the -actin cDNA probe also resulted in the detection of an additional transcript of 1.4 kb in size, corresponding to the myometrial smooth muscle ot-actin mRNA. Significantly elevated levels (p < 0.01) of acl mRNA were also present in the ovaries of RU486-treated animals. Its abundance was increased 8-fold above the control value at 24 h and 5-fold at 48 h. Similar to what was seen in the uterus, the RU486-specific induction of al mRNA was completely inhibited by R 5020 in ovaries. Abundance of ovarian [3-actin mRNA was not affected by administration of the antiprogesterone RU486. Significantly increased amounts (p < 0.01) of ota mRNA, at a level 3-fold over the control group, were also observed in the mesometrial stroma at 24 h or 48 h after a single injection of RU486. Consistent with the effects in the uterus and ovaries, this induction was completely suppressed in the presence of R 5020. The abundance of [-actin mRNA remained constant for all three groups at 24 h; however, it was somewhat elevated at 48 h in the RU486 (1.5-fold) or the RU486+R 5020 group (2-fold). In contrast to the RU486-induced elevation of the a transcript in the uterus, ovary, and mesometrial stroma, RU486 had no noticeable effect on the steady-state level of oa mRNA in the placenta. The abundance of placental [3-actin transcript was not affected by either RU486 or RU486+R 5020 treatment. Taken together, the results of the al transcript analysis obtained from the pooled material were consistent with those derived from individual animals of each group. Moreover, the increase of myometrial GJs analyzed by immunohistochemistry was consistent with the induction of uterine ol mRNA detected by Northern blots. A 15-fold increase in the steady-state level of ao GJ mRNA was directly reflected in a 9-fold increase of GJ frequency, resulting in a 14-fold increase of total surface area of myometrial GJs.
DISCUSSION
The present study provides evidence for multiple and cell type-specific effects of the PR blocker RU486 on the expression levels of aol, PI, and 32 connexins in different compartments of the implantation chamber. In the uterus, the blocking of P action was associated with an up-regulation of al connexin in the myometrium and with a downregulation of 3 connexins in the luminal epithelium. Since these effects were completely suppressed by the synthetic P analog R 5020, it is proposed that these responses were mediated by the blocking of PR pathways.
Multiple Effects of Blocking the PR on the Implantation Chamber During Mid/Late Pregnancy
Analysis of the implantation chamber of animals in preterm labor offered the opportunity to examine both fetal and maternal components following the pharmacologically induced suppression of P action and to make comparisons with those during term labor [5] . Vaginal bleeding, resembling that during term labor, was characteristic for all animals 48 h after RU486 administration. However, in contrast to term labor, in which bleeding was always concomitant with the myometrial contractions leading to the expulsion of fetuses, it is not known whether similar activities of the uterus were present during preterm labor. Although myometrial and epithelial transitions of the preterm uterus are similar to those during term labor [5] , notable differences were detected in the placenta and mesometrial stroma of animals in preterm labor. These differences were marked by the smaller size of both organs, indicating a reduced maternal blood flow. The reduction of the maternal blood supply could also account for a reduced fetal body size. Although the present study provided further evidence for the inhibition of PR pathways during late gestation, it also demonstrated that the blocking of P action at the receptor level was not sufficient to mimic all aspects of spontaneous labor. The failure of the antiprogesterone-treated uterus to expel the concepti, in spite of the vaginal bleeding that was observed around 12 h postinjection, indicated that the administration of RU486 (10 mg/kg BW) to Day 15 pregnant rats was not sufficient to induce a complete abortion. Incomplete detachment of the placenta from the mesometrial stroma supported the interpretation that RU486 was ineffective in inducing parturition. The present observations are consistent with the results of one study [12] in which no deliveries were observed within 48 h. However, delivery of rat fetuses was reported between 30 and 48 h after drug treatment in other studies [10, 17] . Since in all of these studies RU486 was administered s.c. at a dose of 10 mg/kg BW, the discrepancies might be explained by assuming a subthreshold dose of the antiprogesterone being used in the experimental protocol. The failure of RU486 to induce preterm parturition in rats at Day 16 or Day 17 of gestation may also be associated with an incomplete activity of the uterus and the maturation of the cervix. The activity of both organs is controlled by common endocrine factors during parturition [22] . This interpretation is supported by findings from studies using primates and guinea pigs as experimental models of preterm labor [23, 24] . These studies demonstrated that an RU486 contragestive strategy is a twostep process, in which a combination of antiprogesterone with prostaglandin is required for successful termination of gestation.
Regulation of GJ Gene Products in the Uterus by Steroid Hormones
To investigate the cellular and molecular mechanisms for RU486 effects on the expression of different connexins, various components of the implantation chamber were analyzed by immunohistochemistry and Northern blots. The cell type-specific action of the PR antagonist RU486 on al, P3, and 32 GJ gene products in the uterus during experimentally induced preterm labor is consistent with a modulation of these connexins in different cell types during normal rat pregnancy and at term [4, 5] . Collectively, these studies support the notion that the disruption of gestation in rats is closely associated with a reduction of 31 and 132 connexins in GJs of the luminal epithelium and with an induction of al connexins in GJs of the myometrium. The fact that [31 connexin was more sensitive to a down-regulation than 2 in the same tissue suggests that there is an additional level of regulation for individual GJ gene products. The results presented here are also consistent with a recent report demonstrating a cell type-and steroid hormone-specific modulation of different GJ gene products in the E 2 -and P-dominated uterus and ovaries of immature rats [13] . Together, these findings suggest that the multiplicity of RU486 effects were generally due to an inhibition of P action, which in turn shifted the molecular switch of endocrine control toward E 2 dominance. This interpretation is consistent with the autoregulatory mechanisms between E 2 R and PR and their control of gene expression in the uterus and ovaries (see below). The long-lasting effect of RU486 observed in the present study (48 h after a single injection) is in accord with the relatively long half-life of this synthetic steroid hormone [25] .
Potential Role of GJs during Pregnancy and Parturition
Although direct experimental evidence demonstrating a functional role for GJs has been difficult to obtain, several correlative studies have strongly implied that GJ-mediated cell-cell communication is important for the coordination of metabolic and electrical activities within a tissue [26, 27] . In the myometrium, GJs appear to be important in generating a histomechanical force by synchronization of contractions of individual smooth muscle cells [28, 29] . The formation of GJs is intimately linked to this force, triggering the physiological event of parturition [30] [31] [32] . The induction of ai connexin in the circular and longitudinal smooth muscle layers of the myometrium supports this view. However, the activation of the uterus to expel the conceptus at term or preterm labor is a multistep process, including among several other factors the induction of oxytocin receptors in the myometrium [33, 34] .
The results of the present study demonstrated that the blocking of P action at the receptor level was associated with the breakdown of the secretory (P-dominated) luminal epithelium. The disruption of the secretory activity was marked by a dramatic reduction of epithelial GJs, which was particularly noticeable for GJs containing , connexin. These results suggest that an abundant intercellular communication is required to synchronize the activities of the secretory epithelium and to maintain its functional state during gestation. Although the physiological importance of GJs in the mesometrial stroma (metrial gland) is not known, they may be associated with the proliferative activities of this transitory tissue during rat pregnancy. The decreased levels of al connexin proximal to blood vessels may reflect the differences in nutrient supply. In the placenta, which is also a transitory organ composed of maternal (decidua basalis) and fetal (basal zone and labyrinth) components, GJs containing al and 2 connexins may provide pathways for the synchronization of cellular activities that are required for secretion, differentiation, and degradation processes [35] . The increased levels of ao connexin mRNA in ovaries during preterm labor (8-fold over the control) are consistent with an elevated transcript abundance during E 2 -dominated periods [4, 13, 36] . The utilization of hormone-responsive GJ gene products may enable cells within the ovary to establish communication compartments that are required for propagation of intercellular signals and nutrient supply during FIG. 7 . Representative Northern blots of a, connexin and 3-actin mRNAs isolated from different components of the rat implantation chamber at Day 16 and Day 17 of gestation. A) In the displayed blot, tissues of five animals were pooled and used for RNA extraction to assess for differences in transcript abundance between different groups. In addition, tissues were analyzed separately for each rat to assess for the variability between individual animals within each treatment group. All experiments were repeated at least three times. B) Graphical representation of Northern blot data illustrating steady-state levels of ao, connexin and -actin mRNAs in various tissues isolated from individual rats. After the detection of specifically bound probes by autoradiography, the signal intensities were scanned by a densitometer and expressed as mean +_ SD relative to values for the control group, for which the abundance was set at 1.0. The data of individual rats were subjected to statistical analysis to determine the difference of means between different groups. Statistically significant differences were determined by ANOVA followed by Student's t-test. *, Values significantly different from control (p 0.01). Note: Columns without error bars are due to resolution limits of the graph.
well-defined stages of follicular activity such as growth, ovulation, and atresia [37, 38] . The results presented here provide further evidence for regulation of different GJ genes and their products at the transcriptional and/or posttranscriptional level. However, the functional state of GJ channels, and thus the extent of intercellular communication, can also be controlled by posttranslational mechanisms, including protein modification by phosphorylation [39, 40] .
Molecular Mechanisms of Steroid Hormone Action on GJ Gene Expression
The molecular mechanisms by which steroid hormones control the expression of GJ genes remain largely unknown. The localization of E 2 R and PR in the myometrium, stroma, and epithelium of the rat uterus [41, 42] indicates, however, that steroid hormones can directly interact with the target cells via receptor-mediated pathways at the level of gene transcription. In addition, indirect mechanisms, such as cell-cell or cell-extracellular matrix interactions, may also contribute to the regulation and/or modulation of GJ gene expression. The differences in expression levels of a, connexin in different tissues after the blocking of P action may indicate a complex hormonal interplay between E 2 and P that is characteristic of the female reproductive tract. The identification of AP-I (activator protein 1) and E 2 R binding sites in the 5'-flanking region of the al GJ gene [43] [44] [45] suggests that the expression of al connexin may be regulated transcriptionally by a direct interaction with the E 2 R and other nuclear transcriptional factors, including Fos and Jun. These promoter features are consistent with the results of the present study in demonstrating induction of oq expression in the E 2 -dominated uterus (myometrium) and ovaries upon RU486 administration. Steady-state levels of al mRNA increased substantially in both target organs (15-fold in uterus, 8-fold in ovaries), indicating a contribution of transcriptional control mechanism(s). Whether the expression of PI and [3 2 connexins in the uterus is potentially regulated by one or more similar mechanisms remains to be clarified. Further studies, including the analysis of regulatory elements of connexin genes, are clearly required for an understanding of the molecular mechanism(s) that enable steroid hormones to control the expression of multiple GJ gene products in specific target cells.
